Skip to Content
Skip to Content

PACT – RMOA and hazard assessment activities

PACT – RMOA and hazard assessment activities

The Public Activities Coordination Tool (PACT)  lists the substances for which a risk management option analysis (RMOA) or an informal hazard assessment for PBT/vPvB (persistent, bioaccumulative and toxic/very persistent and very bioaccumulative) properties or endocrine disruptor properties is either under development or has been completed since the implementation of the SVHC Roadmap commenced in February 2013.

Please read the information on status and purpose of PACT to learn more concerning this matter.

Further information
  • The PACT will be updated monthly to show the new substances being selected by authorities for RMOA or hazard assessment and to inform about the outcome of these preparatory steps and on the suggested follow-up.
  • Only substances undergoing PBT/vPvB or endocrine disruptor assessment in the REACH context are listed in the PACT. PBT/vPvB or endocrine disruptor assessments carried out under other legislations are not included in the PACT. If a substance is undergoing hazard assessment under the substance evaluation process and discussed in the PBT or endocrine disruptor expert groups,, this is shown in the ‘Follow up' column of the PACT table with the text ‘Substance evaluation under development'.
  • Documents available under the details button: the RMOA conclusion document or the hazard assessment outcome document (once finalised). In addition, the full RMOA document is available if the authority wishes to make this document public. A glossary with further explanation on the technical details of the PACT table, the column headings and the terms used is also provided.

Disclaimer: The information and views set out in the PACT table and in the RMOA and hazard assessment outcome documents are those of the evaluating authority and do not necessarily reflect the position or opinion of the other Member States or ECHA. Neither ECHA nor the evaluating authority nor any person acting on either of their behalves may be held liable for the use which may be made of the information contained therein. Statements made or information contained in the documents are without prejudice to any formal regulatory activities that ECHA or the Member States may initiate at a later stage. RMOAs, hazard assessments and their outcomes are compiled on the basis of information available by the date of the publication of the document.

Substance Details

Name
4,4’-isopropylidenediphenol (bisphenol A; BPA)
EC/List No
201-245-8
CAS Number
80-05-7
Authority Authority carrying out work
Germany
Authority contact details
Federal Institute for Occupational Safety and Health; Division 5 "Federal Office for Chemicals"; Friedrich-Henkel-Weg 1-25; 44149 Dortmund; e-mail: chemg(at)baua.bund.de
Scope (Suspected) hazard(s) or concern(s) considered
ED
Activity Activity being carried out by the authority
RMOA
Latest update
15/08/2017
Inclusion Date Inclusion into PACT of the indicated substance/ activity combination
01/02/2017
Finalisation date (of RMOA or Hazard Assessment)
13/06/2017
Outcome Reports the outcome of the latest recorded activity.
Appropriate to initiate regulatory risk management action
Follow-up Suggested follow-up from the acitivity. Should be read together with ‘Activity’ and ‘Outcome’
SVHC
RMOA conclusion document / Hazard Assessment outcome document
Full RMOA Document
Notes
The conclusion of the endocrine disruption assessment pertains to the environment only

Route: .live1

This website uses cookies to ensure you get the best experience on our websites.

Find out more on how we use cookies.